Effects of Peppermint Oil in Cardiometabolic Outcomes

NCT ID: NCT05071833 Phase: NA Status: COMPLETED Enrollment: 36 Completion: 2022-11-05

Conditions

Cardiometabolic Syndrome

Interventions

Peppermint oil., Placebo

Summary

Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. Previous non-randomized interventions have shown that oral peppermint may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.

Therefore, the primary purpose of the proposed investigation is to test the ability of oral peppermint oil supplementation to improve cardiometabolic parameters in healthy individuals.

Primary Outcome

Systolic blood pressure

Source

ClinicalTrials.gov